𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mass screening for colorectal cancer by testing fecal occult blood

✍ Scribed by Masahide Fujita; Yosuke Nakano; Jun Ohta; Tetsuo Taguchi


Publisher
John Wiley and Sons
Year
1986
Tongue
English
Weight
485 KB
Volume
57
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Population screening for colorectal carc
✍ Michael V. Agrez; Michael Coory; Jill Cockburn πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 66 KB πŸ‘ 1 views

T he results of three randomized controlled trials to evaluate the effectiveness of fecal-occult blood (FOB) testing for colorectal carcinoma have been reported. [1][2][3] Two trials of population-based, biennial FOB screening have reported similar results and have led to the claim that the reductio

A mass screening program for colorectal
✍ David P. Winchester; James H. Shull; Edward F. Scanlon; Joanne V. Murrell; Carol πŸ“‚ Article πŸ“… 1980 πŸ› John Wiley and Sons 🌐 English βš– 428 KB πŸ‘ 2 views

Following five promotional and educational programs on CBS-TV news in Chicago, 54,101 Hemoccult@ kits were requested by the public and distributed by seven cancer detection facilities. Only 14,074 individuals completed the test. Six hundred and seventeen or 4.38% were positive. Two hundred and fifte

Faecal occult blood screening for colore
✍ David K. Whynes; Aileen R. Neilson; Andrew R. Walker; Jack D. Hardcastle πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 105 KB πŸ‘ 1 views

Recently published evidence from two large-scale clinical trials conducted in England and in Denmark suggests that faecal occult blood screening for colorectal cancer significantly reduces mortality. However, before screening can be advocated as part of national health policy, its cost-effectiveness

Colorectal cancer mass-screening: Estima
✍ Guy Launoy; Theresa C. Smith; Stephen W. Duffy; VΓ©ronique Bouvier πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 50 KB πŸ‘ 1 views

Mass screening using the faecal occult blood test (FOBT) can reduce mortality from colorectal cancer. Reliable estimation of FOBT sensitivity is crucial in assessing the potential effectiveness of a mass-screening procedure. Available estimates could be inaccurate because they neglect the temporal a